0

Coronary Risk Factors Collection
 181-200 of 1897 Articles
Articles |  17 June 2008
The Relationship of Coffee Consumption with Mortality
Esther Lopez-Garcia, PhD; Rob M. van Dam, PhD; Tricia Y. Li, MD; et al.
Ann Intern Med. 2008;148(12):904-914. doi:10.7326/0003-4819-148-12-200806170-00003
Articles |  20 May 2008 FREE
The Role of Clinical Uncertainty in Treatment Decisions for Diabetic Patients with Uncontrolled Blood Pressure
Eve A. Kerr, MD, MPH; Brian J. Zikmund-Fisher, PhD; Mandi L. Klamerus, MPH; et al.
Ann Intern Med. 2008;148(10):717-727. doi:10.7326/0003-4819-148-10-200805200-00004
Articles |  20 May 2008
Association of Numeracy and Diabetes Control
Kerri Cavanaugh, MD, MHS; Mary Margaret Huizinga, MD, MPH; Kenneth A. Wallston, PhD; et al.
Ann Intern Med. 2008;148(10):737-746. doi:10.7326/0003-4819-148-10-200805200-00006
Editorials |  20 May 2008
It's Time to Overcome Clinical Inertia
Lawrence S. Phillips, MD; Jennifer G. Twombly, MD, PhD
Ann Intern Med. 2008;148(10):783-785. doi:10.7326/0003-4819-148-10-200805200-00011
Articles |  6 May 2008
Monitoring Cholesterol Levels: Measurement Error or True Change?
Paul P. Glasziou, MBBS, PhD; Les Irwig, MBBS, PhD; Stephane Heritier, PhD; et al.
Ann Intern Med. 2008;148(9):656-661. doi:10.7326/0003-4819-148-9-200805060-00005
Articles |  15 April 2008
Effect of Unrelated Comorbid Conditions on Hypertension Management
Barbara J. Turner, MD, MSEd; Christopher S. Hollenbeak, PhD; Mark Weiner, MD; et al.
Ann Intern Med. 2008;148(8):578-586. doi:10.7326/0003-4819-148-8-200804150-00002
Medicine and Public Policy |  15 April 2008
The International Pharmaceutical Market as a Source of Low-Cost Prescription Drugs for U.S. Patients
Aaron S. Kesselheim, MD, JD; Niteesh K. Choudhry, MD, PhD
Ann Intern Med. 2008;148(8):614-619. doi:10.7326/0003-4819-148-8-200804150-00006
Articles |  1 April 2008
Differences in Kidney Function and Incident Hypertension: The Multi-Ethnic Study of Atherosclerosis
Bryan Kestenbaum, MD, MS; Kyle D. Rudser, PhD; Ian H. de Boer, MD, MS; et al.
Ann Intern Med. 2008;148(7):501-508. doi:10.7326/0003-4819-148-7-200804010-00006
Academia and the Profession |  1 April 2008
Exploring the Geometry of Treatment Networks
Georgia Salanti, PhD; Fotini K. Kavvoura, MD; John P.A. Ioannidis, MD
Ann Intern Med. 2008;148(7):544-553. doi:10.7326/0003-4819-148-7-200804010-00011
Ideas and Opinions |  1 April 2008
The Case for Treating Tobacco Dependence as a Chronic Disease
Michael B. Steinberg, MD, MPH; Amy C. Schmelzer, BA; Donna L. Richardson, LCSW, LCADC; et al.
Ann Intern Med. 2008;148(7):554-556. doi:10.7326/0003-4819-148-7-200804010-00012
Editorials |  4 March 2008
Trials That Matter: The Effect of a Fixed-Dose Combination of an Angiotensin-Converting Enzyme Inhibitor and a Diuretic on the Complications of Type 2 Diabetes
George L. Bakris, MD; Michael Berkwits, MD, MSCE, Deputy Editor
Ann Intern Med. 2008;148(5):400-401. doi:10.7326/0003-4819-148-5-200803040-00012
Articles |  15 January 2008
A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study
Nisha I. Parikh, MD, MPH; Michael J. Pencina, PhD; Thomas J. Wang, MD; et al.
Ann Intern Med. 2008;148(2):102-110. doi:10.7326/0003-4819-148-2-200801150-00005
Reviews |  1 January 2008 FREE
Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension
David B. Matchar, MD; Douglas C. McCrory, MD, MHS; Lori A. Orlando, MD, MHS; et al.
Ann Intern Med. 2008;148(1):16-29. doi:10.7326/0003-4819-148-1-200801010-00189
Reviews |  1 January 2008 FREE
Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
Regina Kunz, MD, MSc(Epi); Chris Friedrich, MD; Marcel Wolbers, PhD; et al.
Ann Intern Med. 2008;148(1):30-48. doi:10.7326/0003-4819-148-1-200801010-00190
Editorials |  1 January 2008 FREE
Inhibitors of the Renin–Angiotensin System: Proven Benefits, Unproven Safety
Patrick S. Parfrey, MD
Ann Intern Med. 2008;148(1):76-77. doi:10.7326/0003-4819-148-1-200801010-00191
Editorials |  16 October 2007
Rosiglitazone: A Thunderstorm from Scarce and Fragile Data
Cynthia D. Mulrow, MD, MSc, Deputy Editor; John Cornell, PhD, Associate Editor; A. Russell Localio, PhD, Associate Editor
Ann Intern Med. 2007;147(8):585-587. doi:10.7326/0003-4819-147-8-200710160-00013
Articles |  18 September 2007 FREE
Effects of Aerobic Training, Resistance Training, or Both on Glycemic Control in Type 2 Diabetes: A Randomized Trial
Ronald J. Sigal, MD, MPH; Glen P. Kenny, PhD; Normand G. Boulé, PhD; et al.
Ann Intern Med. 2007;147(6):357-369. doi:10.7326/0003-4819-147-6-200709180-00005
Articles |  18 September 2007
Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men
Amir Tirosh, MD, PhD; Assaf Rudich, MD, PhD; Tzippora Shochat, MSc; et al.
Ann Intern Med. 2007;147(6):377-385. doi:10.7326/0003-4819-147-6-200709180-00007
Reviews |  18 September 2007 FREE
Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus
Shari Bolen, MD, MPH; Leonard Feldman, MD; Jason Vassy, MD, MPH; et al.
Ann Intern Med. 2007;147(6):386-399. doi:10.7326/0003-4819-147-6-200709180-00178
Editorials |  18 September 2007
Exercise Training for Diabetes: The “Strength” of the Evidence
William E. Kraus, MD; Benjamin D. Levine, MD
Ann Intern Med. 2007;147(6):423-424. doi:10.7326/0003-4819-147-6-200709180-00013
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)